Two Sigma Investments, LP Aclaris Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 907,916 shares of ACRS stock, worth $2.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
907,916
Previous 1,113,072 18.43%
Holding current value
$2.63 Million
Previous $1.22 Million 16.26%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.12 - $1.4 $229,774 - $287,218
-205,156 Reduced 18.43%
907,916 $1.03 Million
Q2 2024

Aug 14, 2024
SELL
$1.01 - $1.36 $218,709 - $294,499
-216,544 Reduced 16.29%
1,113,072 $1.22 Million
Q1 2024

May 15, 2024
SELL
$0.92 - $1.44 $123,137 - $192,736
-133,845 Reduced 9.15%
1,329,616 $1.65 Million
Q4 2023

Feb 14, 2024
BUY
$0.64 - $6.49 $920,039 - $9.33 Million
1,437,561 Added 5550.43%
1,463,461 $1.54 Million
Q3 2023

Nov 14, 2023
BUY
$6.56 - $10.95 $169,904 - $283,605
25,900 New
25,900 $177,000
Q1 2023

May 15, 2023
BUY
$7.07 - $17.95 $521,355 - $1.32 Million
73,742 Added 689.18%
84,442 $683,000
Q4 2022

Feb 14, 2023
BUY
$14.33 - $18.37 $153,331 - $196,559
10,700 New
10,700 $168,000
Q1 2022

May 16, 2022
SELL
$9.74 - $17.92 $127,048 - $233,748
-13,044 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$12.27 - $18.49 $1.19 Million - $1.79 Million
-96,784 Reduced 88.12%
13,044 $190,000
Q3 2021

Nov 15, 2021
SELL
$13.38 - $18.8 $3.55 Million - $4.99 Million
-265,474 Reduced 70.74%
109,828 $1.98 Million
Q2 2021

Aug 16, 2021
BUY
$17.08 - $29.6 $3.44 Million - $5.96 Million
201,226 Added 115.6%
375,302 $6.59 Million
Q1 2021

May 17, 2021
BUY
$5.86 - $27.73 $515,586 - $2.44 Million
87,984 Added 102.2%
174,076 $4.39 Million
Q4 2020

Feb 16, 2021
BUY
$2.65 - $7.61 $228,143 - $655,160
86,092 New
86,092 $557,000
Q3 2019

Nov 14, 2019
SELL
$0.79 - $2.47 $56,548 - $176,805
-71,581 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$2.13 - $7.06 $196,207 - $650,338
-92,116 Reduced 56.27%
71,581 $157,000
Q1 2019

May 15, 2019
BUY
$5.63 - $7.84 $328,611 - $457,605
58,368 Added 55.41%
163,697 $981,000
Q4 2018

Feb 14, 2019
BUY
$6.3 - $15.4 $663,572 - $1.62 Million
105,329 New
105,329 $778,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email